ClinicalTrials.Veeva

Menu

Evaluation of Patients With Diffuse Parenchymal Lung Diseases Regarding Frailty

H

Hacettepe University

Status

Not yet enrolling

Conditions

Physical Inactivity
Frailty
Diffuse Parenchymal Lung Disease

Study type

Observational

Funder types

Other

Identifiers

NCT06171425
GO 23/18

Details and patient eligibility

About

There are very few studies in the literature examining the frailty levels of diffuse parenchymal lung disease (DPLD) patients and its effect on their functional status despite the high prevalance of frailty in patients with DPLD This observational study aims to learn about the relationship between frailty and functional capacity and balance in DPLD patients compared to healthy subjects.

Full description

The aim of the study is to evaluate the relationship between the level of frailty and exercise capacity, respiratory functions, diffusion capacity, balance level, postural changes, activities of daily living, peripheral muscle strength and quality of life parameters in DPLD patients. The second aim is to compare diffuse parenchymal lung patients and the healthy control group in terms of these parameters.

Enrollment

28 estimated patients

Sex

All

Ages

30 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Being diagnosed with Diffuse parenchymal lung according to the American Thoracic Society/European Respiratory Society (ATS/ERS) criteria,
  • Being between the ages of 30-65,
  • Being literate,
  • Being willing to participate in the research,
  • Being clinically stable and having any accompanying comorbid conditions (such as hypertension, diabetes) under control,
  • Not having any orthopedic, metabolic or neurological problems that may prevent evaluation of peripheral muscle strength, balance and exercise capacity.

Exclusion criteria

  • Having recently experienced syncope,
  • Having a history of unstable cardiovascular disease,
  • Having been hospitalized due to exacerbation in the last 3 months,
  • Having received pulmonary rehabilitation in the last 12 months,
  • Having a neurological disease,
  • Being dependent and using a walking aid while performing the person's daily life activities,
  • Having a pacemaker,
  • Having a diagnosis of lung cancer

Trial design

28 participants in 2 patient groups

DPAH group
Description:
patients with diffuse parenchymal lung diseases
control group
Description:
aged matched healthy patients

Trial contacts and locations

1

Loading...

Central trial contact

Aynur Demirel; AYNUR DEMIREL, Assoc. Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems